Clin2
NCT07071649Likely a fitRecruiting

Blood test for Alzheimer's compared with spinal fluid test

Alzheimer's DiseaseBiomarkersNon-invasive DiagnosisPhosphorylated Protein p-tau217

Part of Brain & nervous system, Mental health clinical trials.

This study is testing a simple blood test (p-Tau217) as a possible way to diagnose Alzheimer's disease. If it works, it might replace the need for a spinal tap. The results will be compared with the usual spinal fluid markers.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are being checked for possible Alzheimer's disease at the Amiens University Hospital memory clinic.
  • Your doctor has already suggested a lumbar puncture (a spinal tap) to look for Alzheimer's markers in your spinal fluid.
  • You are at least 18 years old.
  • You are not pregnant.
  • You are not under legal guardianship (someone else making decisions for you).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06477484Recruiting
Blood tests to help screen for Alzheimer's

This study is testing whether blood-based markers can help identify Alzheimer's disease earlier. It is for people with Alzheimer's, mild memory problems, or no memory issues at all.

Beijing, Beijing Municipality
NCT07666113Recruiting
Blood test for Alzheimer's disease detection in primary care

This study tests whether a simple blood test can help detect Alzheimer's disease in people who visit their primary care doctor with memory concerns. It aims to improve early diagnosis at the community level.

Leuven
NCT06582199Recruiting
Personalized Alzheimer's study using brain scans and spinal fluid

This study looks at how to better predict and understand Alzheimer's disease by using advanced brain scans and spinal fluid tests. It aims to find ways to identify people who stay healthy longer despite risk factors.

Paris
NCT05288842Recruiting
Study spinal fluid and brain changes in dementia types

This study looks at spinal fluid and MRI results in people with Alzheimer’s disease, frontotemporal dementia, or normal thinking (controls). It aims to understand differences in brain-related cells and measure what might help explain or track these conditions.

Lille
NCT07680335Recruiting
Blood test to help diagnose Alzheimer's earlier

This study is testing whether a simple blood test can help doctors diagnose Alzheimer's disease earlier and more accurately. It's for people who are having memory or thinking problems and are visiting a memory clinic.

Amsterdam, North Holland
NCT06699992Not yet recruiting
Blood tests as a screening tool for Alzheimer's disease

This study compares a new blood test with the standard spinal tap to see if it can help diagnose Alzheimer's disease. It is for people who are already scheduled for a spinal tap as part of their memory evaluation.

Roma, Roma

Hear when a new Alzheimer’s disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.